OGE
NYSE · Utilities
Oge Energy Corp
$47.69
+0.39 (+0.82%)
OGE News30 articles
AbbVie Acquires Apogee Therapeutics for $10.9B in Cash, Bolstering Pipeline
AbbVie announced a $10.9 billion cash acquisition of Apogee Therapeutics, adding a promising eczema treatment to its pipeline as it seeks to offset declining Humira sales.
AbbVie to Acquire Apogee Therapeutics for $10.9 Billion in Cash
Apogee Therapeutics stock jumped 47% after AbbVie agreed to buy the company for $135.11 per share in cash, adding late-stage eczema drug zumilokibart.
AbbVie to Buy Apogee in $10.9B Deal to Boost Immunology Pipeline
AbbVie acquires Apogee Therapeutics for $10.9 billion, paying a 49.49% premium for experimental eczema drug zumilokibart, as it seeks to bolster its immunology franchise.
AbbVie Nears $10.9B Apogee Takeover, Healthcare Stocks in Focus
AbbVie is reportedly close to acquiring Apogee Therapeutics for $10.9 billion in cash, offering a roughly 60% premium. A deal could be announced Monday, putting healthcare stocks in the spotlight.
Plug Power Stock Jumps 7.5% as Tax Credit Sale Boosts Liquidity, Hydrogen Sector Rallies
Plug Power shares jumped 7.55% on Thursday, driven by a $39.2 million tax credit sale and improved gross margins, as the hydrogen sector broadly rallied.
Kroger Shares Dip as Q1 Profit Misses Estimates Despite Revenue Beat
Kroger shares dropped 3% premarket after Q1 adjusted profit missed estimates by a cent, despite a sales beat. Margin pressure from price cuts and transport costs raised investor doubts.
PEPE Outpaces DOGE and SHIB as Meme Coins Test Key Resistance Levels
PEPE outperformed DOGE and SHIB on short-term momentum, but analysts caution the rally could end quickly if key resistance levels aren't breached.
Rogers Corp. Surges on AI Materials Demand; Global Markets React to Regulatory and IPO News
Rogers Corp. shares surged 4% on demand growth and AI materials progress. China's regulator warns against AI stock speculation. BSE shares fall as NSE prepares for a major IPO. C3.ai may be overvalued by 45%.
Plug Power Slips Again as Hydrogen Rally Faces Profitability Test
Plug Power shares fell 4.1% to $3.95 on Friday, as the hydrogen rally faces a critical test of profitability and cash management.
Plug Power Stock Holds Above $4 as Hydrogen Optimism Returns
Plug Power shares trade near $4.12 after a volatile week, with Q1 revenue growing 22% and a $246M net loss. The company advances its UK green hydrogen project and targets EBITDAS profitability by Q4.
Plug Power Stock Steadies as UK Hydrogen Project Advances
Plug Power shares closed Tuesday up 1.59% at $3.84. The company's Barrow Green Hydrogen project in the UK has reached final investment decision, but profitability remains elusive with a Q1 net loss of $246 million.
Plug Power Ends Flat After Volatile Week; Barrow Hydrogen Project Reaches FID
Plug Power shares ended the week unchanged at $3.78 following a volatile trading period. The Barrow Green Hydrogen project reached final investment decision, but cash burn and margins remain key investor concerns.
Apellis Delisted After Biogen's $5.3B Acquisition Closes
Biogen closed its $5.3 billion acquisition of Apellis, ending APLS trading on Nasdaq. Shareholders got $41 per share plus a CVR linked to Syfovre sales milestones.
Plug Power's UK Green Hydrogen Project Reaches FID, Stock Flat
Plug Power's Barrow Green Hydrogen project hits FID, supplying six 5 MW electrolyzers to cut Kimberly-Clark's gas use 50%. Stock flat at $3.31 as cash risks remain.
Plug Power Advances UK Hydrogen Project Amid Cash Concerns
Plug Power shares climbed 1.2% to $3.35 after achieving final investment decision for its 30-MW green hydrogen project in the UK, though cash constraints and negative margins remain key concerns.
Biogen Closes Apellis Takeover; Focus Shifts to Syfovre Milestones
Biogen has completed its $5.6 billion acquisition of Apellis Pharmaceuticals, delisting APLS from Nasdaq. Shareholders received $41 per share plus a contingent value right linked to Syfovre sales targets.
Kroger Stock Climbs as CEO Focuses on Price Strategy
Kroger shares gained 3.8% in midday trading Tuesday, outpacing Walmart and Costco, as investors focus on new CEO Greg Foran's pricing strategy.
Apellis Delisted After Biogen Buyout; CVR Payout in Focus
Apellis Pharmaceuticals has been delisted from Nasdaq following Biogen's completed acquisition. Shareholders get $41 per share plus a contingent value right worth up to $4 if Syfovre meets sales goals.
Biogen Closes Apellis Takeover; CVR Offers Upside
Biogen completed its $41/share cash acquisition of Apellis, delisting the stock from Nasdaq. Shareholders also received a contingent value right that could pay up to $4 if Syfovre sales hit targets.
Biogen Completes Apellis Takeover, Gains Rare-Disease Pipeline
Biogen has completed its acquisition of Apellis Pharmaceuticals, delisting APLS shares. Biogen gains Syfovre and Empaveli, plus a kidney disease pipeline, with a CVR tied to Syfovre sales.
Biogen Completes Apellis Takeover, Ending Nasdaq Listing
Biogen closed its $5.3 billion acquisition of Apellis Pharmaceuticals, making Apellis a wholly owned subsidiary and ending its Nasdaq listing.
DoorDash Enables SNAP Payments for Kroger Delivery Across 2,700 Stores
DoorDash has begun accepting SNAP/EBT payments for grocery delivery from nearly 2,700 Kroger-family stores, expanding low-income food access and intensifying competition with Uber Eats and Instacart.
Biogen Lowers 2026 Profit View Despite Q1 Beat; Leqembi Sales Soar 74%
Biogen lowered its 2026 adjusted earnings outlook to $14.25-$15.25 per share after Q1 results topped estimates. Leqembi sales jumped 74% to $168M globally.
Dogecoin Surges Past $0.10, But Rising Leverage Poses Reversal Risk
Dogecoin rallied 10.9% to $0.1101, clearing the $0.10 resistance, but a 33% jump in futures open interest raises the risk of a sudden sell-off.
Plug Power Surges on Major Quebec Hydrogen Deal Ahead of Investor Tour
Plug Power shares rallied sharply following a significant electrolyzer contract award in Quebec. Company leadership is commencing a Canadian investor roadshow to discuss financial progress and growth strategy.
Plug Power Secures Major Electrolyzer Contract for Quebec Green Hydrogen Project
Plug Power has been selected to provide a 275-megawatt electrolyzer system for Hy2gen Canada's Courant green hydrogen project in Quebec, sending its shares up 7%.
Biogen Acquires Apellis in $5.6B Deal, Adding Eye and Kidney Drugs
Biogen has entered a definitive agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion. The deal includes a $41 per share cash offer plus contingent value rights.
Biogen to Acquire Apellis in $5.6B Deal, Adding Rare Disease Portfolio
Biogen has entered an agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion in cash. The deal provides Apellis shareholders $41 per share upfront, with potential additional payments based on sales performance of the eye drug Syfovre.
Plug Power Targets AI Data Center Demand with Major Hydrogen Power Bid
Plug Power is bidding 250 megawatts of hydrogen-generated electricity into a potential PJM Interconnection auction to supply growing AI data center demand, as the company works to address a $1.7 billion annual loss through asset sales and financing.
Kroger Appoints Walmart Veteran Greg Foran as CEO, Shares Gain Slightly
Kroger has named former Walmart executive Greg Foran as its new chief executive, with a compensation package including a $1.5 million base salary and up to $12 million in annual stock awards. Shares rose 0.4% following the announcement.